Evidence map›Paper›PMID 21535997›Full record

Trial reportThe Journal of clinical psychiatry2011

A randomized, double-blind, placebo-controlled study of light therapy for antepartum depression.

Anna Wirz-Justice, Anja Bader, Ulrike Frisch, Rolf-Dieter Stieglitz, Judith Alder, Johannes Bitzer, Irene Hösli, Sandra Jazbec, Francesco Benedetti, Michael Terman and 2 more

4 registry-linked trialsAbstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in The Journal of clinical psychiatry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 68 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed, 4 pooled it
14.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01043289 nacompletednot on this map

A Randomised, Double-blind, Placebo-controlled Study of Light Therapy for Antepartum Depression

TypeinterventionalSponsorPsychiatric Hospital of the University of BaselRan2004 to 2008Enrolled46ConditionsMajor Depressive Disorder, PregnancyArmsLight therapy
NCT02621567 phase4completednot on this mapstarted 2016, after this paper: background citation

Bright Light Therapy Efficacy for Depressive Symptoms Following Cardiac Surgery or Acute Coronary Syndrome: Pilot Trial

TypeinterventionalSponsorMcGill UniversityRan2016 to 2017Enrolled15ConditionsDepressive Symptoms Post Cardiac Surgery or Post Acute Coronary SyndromeArmsBright Light Therapy Lamp, Modified Dim Lamp
NCT05823090 phase4completednot on this mapstarted 2021, after this paper: background citation

Light Therapy for Depression in Adolescent Outpatients: A Placebo lead-in Clinical Trial

TypeinterventionalSponsorAnn & Robert H Lurie Children's Hospital of ChicagoRan2021 to 2022Enrolled9ConditionsDepression, Adolescent - Emotional ProblemArmslight box (Carex DayLight Classic Model)
NCT05939453 narecruitingnot on this mapstarted 2023, after this paper: background citation

A Randomized, Double-Blind, Controlled Trial of Bright Light Therapy on All-Cause Excessive Daytime Sleepiness in Prader-Willi Syndrome

TypeinterventionalSponsorMaimonides Medical CenterRan2023 to 2026Enrolled50ConditionsPrader-Willi Syndrome, Excessive Daytime Sleepiness, Hyperphagia, Body WeightArmsSham Light, Bright Light Therapy
3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 4 syntheses or guidelines pooled it, 235 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Chronotherapeutic treatments for depression in youth.European child & adolescent psychiatry · 2016
    Trial
  14. Trial
  15. Trial
  16. Article
  17. Chronotherapy in the Treatment of Major Depression.Advances in experimental medicine and biology · 2026
    Review
  18. Review
  19. Review
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Anna Wirz-JusticeCentre for Chronobiology, Psychiatric Hospitals of the University of Basel, Wilhelm Klein Strasse 27, CH-4012 Basel, Switzerland. anna.wirz-justice@unibas.ch
Anja Bader
Ulrike Frisch
Rolf-Dieter Stieglitz
Judith Alder
Johannes Bitzer
Irene Hösli
Sandra Jazbec
Francesco Benedetti
Michael Terman
Katherine L Wisner
Anita Riecher-Rössler
University of Basel · CHColumbia University · USUniversity of Pittsburgh · USVita-Salute San Raffaele University · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveAffective disorder during pregnancy is a common condition requiring careful judgment to treat the depression while minimizing risk to the fetus. Following up on promising pilot trials, we studied the efficacy of light therapy.

methodTwenty-seven pregnant women with nonseasonal major depressive disorder according to DSM-IV (outpatients, university polyclinic) were randomly assigned to 7,000 lux fluorescent bright white or 70 lux dim red (placebo) light administered at home in the morning upon awakening for 1 h/d in a 5-week double-blind trial carried out between October 2004 and October 2008. Clinical state was monitored weekly with the 29-item Structured Interview Guide for the Hamilton Depression Rating Scale (HDRS) with Atypical Depression Supplement (SIGH-ADS). Changes of rating scale scores over time were analyzed with the general linear model. Differences from baseline of SIGH-ADS and 17-item HDRS scores at every time point were the dependent variables, time was the within-subjects factor, and treatment was the between-subjects factor. The model also included baseline score of depression and gestational age at intervention start.

resultsThe superiority of bright light over dim light placebo was shown for both SIGH-ADS (R² = 0.251; F(3,23) = 3.91; P < .05) and HDRS (R² = 0.338; F(3,23) = 5.42; P < .01) when analyzing the week-by-week change from baseline, and HDRS scores showed a significant interaction of treatment with time (F(4,92) = 2.91; P < .05). Categorical analysis revealed that the response rate (HDRS ≥ 50% improvement) at week 5 was significantly greater for bright light (81.3%, n = 16) than for placebo light (45.5%, n = 11) (P < .05). Remission (final score ≤ 8) was attained by 68.6% versus 36.4%, respectively (P < .05). Expectation ratings did not differ significantly between groups.

conclusionsBright white light treatment for 5 weeks improved depression during pregnancy significantly more than placebo dim red light. The study provides evidence that light therapy, a simple, cost-effective antidepressant modality with minimal side effects for the mother and no known risk for the unborn child, may be a useful nonpharmacologic approach in this difficult situation.

trial registrationclinicaltrials.gov Identifier: NCT01043289.

Indexed as

PhototherapyAdolescentAdultDouble-Blind MethodFemaleHumansMajor Depressive DisorderPersonality InventoryPregnancyPregnancy ComplicationsPsychometricsSwitzerlandYoung Adult

Identifiers

PMID21535997
OpenAlexW2115800810

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.